Literature DB >> 1330539

A regulatory element that mediates co-operation between a PEA3-AP-1 element and an AP-1 site is required for phorbol ester induction of urokinase enhancer activity in HepG2 hepatoma cells.

C Nerlov1, D De Cesare, F Pergola, A Caracciolo, F Blasi, M Johnsen, P Verde.   

Abstract

We have characterized a transcriptional enhancer of the human urokinase-type plasminogen activator (uPA) gene and found a regulatory element required for co-operation between a PEA3--AP-1 element and an AP-1 site in the enhancer. We designated this regulatory element co-operation mediator (COM). Both the PEA3--AP-1 element, the AP-1 site and the COM are required for efficient phorbol ester induction of transcription from the uPA promoter in the HepG2 hepatoma cell line. We show that the COM is also required for co-operation between the PEA3--AP-1 element and a glucocorticoid response element, both in the presence or absence of TPA, indicating that the COM is generally capable of mediating synergism between inducible enhancer elements. The COM contains multiple overlapping binding sites for nuclear proteins, designated uPA enhancer factors 1-4 (UEF-1-4). We have identified putative binding sites for UEF-1, -2 and -3. The UEF-1 and -3 sites in the uPA enhancer are highly conserved between species. We demonstrate the binding of UEF-3 to the NIP element, a previously characterized regulatory element in the human interleukin-3 and stromelysin promoters, suggesting that this factor plays a role in regulation of a variety of genes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1330539      PMCID: PMC557033          DOI: 10.1002/j.1460-2075.1992.tb05559.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  46 in total

1.  Transcription cell type specificity is conferred by an immunoglobulin VH gene promoter that includes a functional consensus sequence.

Authors:  J O Mason; G T Williams; M S Neuberger
Journal:  Cell       Date:  1985-06       Impact factor: 41.582

2.  Positive and negative elements regulate human interleukin 3 expression.

Authors:  B Mathey-Prevot; N C Andrews; H S Murphy; S G Kreissman; D G Nathan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

3.  Localization of urokinase-type plasminogen activator in stromal cells in adenocarcinomas of the colon in humans.

Authors:  J Grøndahl-Hansen; E Ralfkiaer; L T Kirkeby; P Kristensen; L R Lund; K Danø
Journal:  Am J Pathol       Date:  1991-01       Impact factor: 4.307

4.  Antibodies to plasminogen activator inhibit human tumor metastasis.

Authors:  L Ossowski; E Reich
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

5.  Constitutive expression of the urokinase plasminogen activator gene in murine RAW264 macrophages involves distal and 5' non-coding sequences that are conserved between mouse and pig.

Authors:  A I Cassady; K J Stacey; K A Nimmo; K M Murphy; D von der Ahe; D Pearson; F M Botteri; Y Nagamine; D A Hume
Journal:  Nucleic Acids Res       Date:  1991-12-25       Impact factor: 16.971

6.  Identification and primary sequence of an unspliced human urokinase poly(A)+ RNA.

Authors:  P Verde; M P Stoppelli; P Galeffi; P Di Nocera; F Blasi
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

7.  Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas.

Authors:  C Pyke; P Kristensen; E Ralfkiaer; J Grøndahl-Hansen; J Eriksen; F Blasi; K Danø
Journal:  Am J Pathol       Date:  1991-05       Impact factor: 4.307

8.  Interleukin-1 or phorbol induction of the stromelysin promoter requires an element that cooperates with AP-1.

Authors:  K Sirum-Connolly; C E Brinckerhoff
Journal:  Nucleic Acids Res       Date:  1991-01-25       Impact factor: 16.971

9.  The 5'HS2 of the globin locus control region enhances transcription through the interaction of a multimeric complex binding at two functionally distinct NF-E2 binding sites.

Authors:  D Talbot; F Grosveld
Journal:  EMBO J       Date:  1991-06       Impact factor: 11.598

10.  Increase in urokinase plasminogen activator mRNA synthesis in human carcinoma cells is a primary effect of the potent tumor promoter, phorbol myristate acetate.

Authors:  M P Stoppelli; P Verde; G Grimaldi; E K Locatelli; F Blasi
Journal:  J Cell Biol       Date:  1986-04       Impact factor: 10.539

View more
  25 in total

1.  GATA6 promotes colon cancer cell invasion by regulating urokinase plasminogen activator gene expression.

Authors:  Narasimhaswamy S Belaguli; Muhammad Aftab; Mohammed Rigi; Mao Zhang; Daniel Albo; David H Berger
Journal:  Neoplasia       Date:  2010-11       Impact factor: 5.715

2.  Oncogenic ETS proteins mimic activated RAS/MAPK signaling in prostate cells.

Authors:  Peter C Hollenhorst; Mary W Ferris; Megan A Hull; Heejoon Chae; Sun Kim; Barbara J Graves
Journal:  Genes Dev       Date:  2011-10-15       Impact factor: 11.361

3.  Role of distinct mitogen-activated protein kinase pathways and cooperation between Ets-2, ATF-2, and Jun family members in human urokinase-type plasminogen activator gene induction by interleukin-1 and tetradecanoyl phorbol acetate.

Authors:  G Cirillo; L Casalino; D Vallone; A Caracciolo; D De Cesare; P Verde
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

4.  TRANSFAC, TRRD and COMPEL: towards a federated database system on transcriptional regulation.

Authors:  E Wingender; A E Kel; O V Kel; H Karas; T Heinemeyer; P Dietze; R Knüppel; A G Romaschenko; N A Kolchanov
Journal:  Nucleic Acids Res       Date:  1997-01-01       Impact factor: 16.971

5.  Synergistic transcriptional activation of the mouse urokinase plasminogen activator (uPA) gene and of its enhancer activator protein 1 (AP1) site by cAMP and retinoic acid.

Authors:  R Mira-Y-Lopez; S Jaramillo; Y Jing
Journal:  Biochem J       Date:  1998-05-01       Impact factor: 3.857

Review 6.  Role of Ets transcription factors in mammary gland development and oncogenesis.

Authors:  T Shepherd; J A Hassell
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-01       Impact factor: 2.673

7.  Differential regulation of plasminogen activator and inhibitor gene transcription by the tumor suppressor p53.

Authors:  C Kunz; S Pebler; J Otte; D von der Ahe
Journal:  Nucleic Acids Res       Date:  1995-09-25       Impact factor: 16.971

8.  Recognition of distinct HLA-DQA1 promoter elements by a single nuclear factor containing Jun and Fos or antigenically related proteins.

Authors:  M Neve Ombra; M Autiero; A DeLerma Barbaro; R Barretta; G Del Pozzo; J Guardiola
Journal:  Nucleic Acids Res       Date:  1993-04-25       Impact factor: 16.971

Review 9.  Invasion and metastasis.

Authors:  D Boyd
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

10.  Cell Adhesion and Transcriptional Activity - Defining the Role of the Novel Protooncogene LPP.

Authors:  Thomas Gp Grunewald; Saskia M Pasedag; Elke Butt
Journal:  Transl Oncol       Date:  2009-08-18       Impact factor: 4.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.